Clinical Trials on Neack and Head Cancer in Hungary
Total 650 results
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerFrance, Poland, Taiwan, Spain, Israel, Belgium, Russian Federation, Czech Republic, Hungary, Australia
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
BioNTech SERecruitingNon-Small Cell Lung CancerSpain, Germany, Turkey, United States, Hungary, United Kingdom, Poland
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
CytRxUnknownMetastatic Small Cell Lung CancerUnited States, Spain, Hungary
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
Axelar ABCompletedNon-small-cell Lung Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the LungRussian Federation, Ukraine, Belarus, Hungary, Poland
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
PfizerTerminatedNon-Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Hoffmann-La RocheCompletedBreast CancerEstonia, Hungary, Turkey, Israel, Slovakia, Bulgaria, Lithuania, Macedonia, The Former Yugoslav Republic of
-
Central European Cooperative Oncology GroupCompletedMetastatic Breast CancerSerbia, Israel, Croatia, Hungary, Poland, Bosnia and Herzegovina, Latvia, Slovakia, Austria, Czechia, Bulgaria, Romania
-
Bristol-Myers SquibbCompletedLung Cancer (NSCLC)China, Germany, Singapore, Hungary, Korea, Republic of, Poland
-
BioNTech SETerminatedProstate CancerUnited States, Germany, United Kingdom, Hungary
-
SanofiActive, not recruitingNon-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Spain, United States, Brazil, Chile, Czechia, France, Hungary, Israel
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Medtronic Spine LLCCompletedCancer | Spinal FracturesUnited States, Canada, Australia, Sweden, Belgium, Germany, Hungary, United Kingdom
-
Daiichi Sankyo, Inc.CompletedCancer | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)United States, Netherlands, Italy, Belgium, France, Hungary
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
G1 Therapeutics, Inc.RecruitingExtensive-stage Small-cell Lung CancerSpain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
AstraZenecaCompletedPancreatic CancerUnited States, Bulgaria, Hungary, Romania, Australia
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerBelgium, Bosnia and Herzegovina, Bulgaria, Egypt, Estonia, Germany, Hungary, Italy, Lithuania, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Taiwan
-
SynCore Biotechnology Co., Ltd.CompletedPancreatic Adenocarcinoma | Metastatic Pancreas Cancer | Locally Advanced Pancreatic CancerUnited States, Korea, Republic of, Taiwan, France, Hungary, Israel, Russian Federation
-
Microvention-Terumo, Inc.UnknownIntracranial Aneurysms | Wide Neck Bifurcation Intracranial AneurysmsUnited States, Denmark, Canada, Hungary, Germany, Turkey
-
Ferring PharmaceuticalsCompletedProstate CancerNetherlands, Belgium, Germany, Russian Federation, South Africa, Hungary, Romania, Poland
-
AstraZenecaCompletedObesity | Prostate CancerHungary
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
ETOP IBCSG Partners FoundationHoffmann-La RocheRecruitingBreast CancerIreland, Italy, Germany, Spain, Hungary, France, Sweden, Switzerland
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
European Organisation for Research and Treatment...Institute of Cancer Research, United Kingdom; Arbeitsgruppe Lebermetastasen...TerminatedColorectal Cancer | Metastatic CancerNetherlands, United Kingdom, Belgium, France, Germany, Sweden, Hungary, Austria, Egypt, Italy
-
Elevation OncologyMerrimack PharmaceuticalsTerminatedAdenocarcinoma | Non-Small Cell Lung Cancer | NSCLC | HeregulinSpain, Canada, United States, Germany, Hungary, France
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia